Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.80    1.00 (0.98%)
Bid:
102.60
Ask:
103.20
Spread: 0.60 (0.585%)
Market Cap: £168.53m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

AGM & Interim Management Statement

14 May 2009 07:00

RNS Number : 1992S
Yule Catto & Co PLC
14 May 2009
 

14 May 2009

Yule Catto & Co plc 

AGM and Interim Management Statement

At today's Annual General Meeting of Yule Catto & Co plc, an international producer of speciality chemicals, Peter Wood, Chairman, will make the following statement, which comprises Yule Catto's Interim Management Statement for the period from 1 January 2009 to date.

Trading update

2009 has started satisfactorily given the very difficult macro economic environment. The Group has benefited from the weakness of sterling, and overall the Group has traded in line with management expectations.

In Polymer Chemicals, the substantial volume declines seen in the fourth quarter of 2008 persisted into 2009 although March was slightly better than the first two months of the year.

Pharma Chemicals had a good first quarter compared to what was a relatively weak start to 2008. Profits were in line with our expectations for a stronger full year performance in 2009. 

William Blythe, the remaining Impact Chemicals business was ahead of last year as expected, and benefited from the restructuring implemented at the end of the first quarter of 2008.

The Group announced a number of cost reduction initiatives with its full year 2008 results which are on track.

Following the successful refinancing at the year end with a new revolving finance facility and Malaysian term loan, the Group is making good progress on its debt reduction target. 

Looking forward we continue to expect the Pharma business to deliver higher profits than 2008, assisted by the favourable €/$ exchange rate and increased capacities for a number of products. Similarly William Blythe should continue to trade satisfactorily following its restructuring. Volume declines in Polymers moderated at the end of the first quarter but the outlook for the balance of the year remains uncertain. A large proportion of the Polymer Division's sales are in Europe and Asia and hence we are currently benefiting from the weakness of sterling. Given the uncertainty in our end markets, it is difficult to give any firm guidance on the outturn for Polymers for the full year and hence the Group as a whole.

Board Changes

Further to the retirement of Anthony Richmond-Watson, two other non executive directors will be retiring at this Annual General Meeting:- Dato' Seri Lee Oi Hian, who joined the Board in 1981 and is Chief Executive of Kuala Lumpur Kepong Bhd which has been a major shareholder in the Company since 1976; and Richard Hunting, an independent non executive director, who joined the Board in 2000 and has been Chairman of the Nomination Committee since 2001 and a member of the Audit Committee for nine years. I would like to thank all of them for their valuable contribution to the Group.

We are delighted to welcome Graham Menzies who joined the Board on 1 March this year. Graham's biographical details are in the circular that accompanied the 2008 Annual Report and he has been appointed as the Senior Independent Director after a distinguished career as a public company chief executive.

These changes complete the realignment of our Board structure and we believe that the Board, as currently constituted, is appropriate and balanced to serve the future needs of the Group.

ENQUIRIES:

YULE CATTO & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Finance Director 

 

HOGARTH PARTNERSHIP

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSAJMATMMBBBBL
Date   Source Headline
11th Nov 20212:24 pmRNSDirector/PDMR Shareholding
4th Nov 20212:11 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSNew Chief Executive
28th Oct 20213:17 pmRNSResult of Placing
28th Oct 20217:00 amRNSAcquisition
28th Oct 20217:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
30th Sep 20213:08 pmRNSDirectorate Change
10th Sep 20218:23 amRNSDirector Declaration
5th Aug 20217:01 amRNSBoard Update
5th Aug 20217:00 amRNSInterim Results
20th Jul 202112:05 pmRNSSynthomer plc receives Green Economy Mark
19th Jul 20217:00 amRNSTrading Update
14th Jul 202111:02 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSAppointment of Non-Executive Director
6th Jul 202112:37 pmRNSDirector/PDMR Shareholding
25th Jun 202110:01 amRNSFurther re Appointment of Group CEO
23rd Jun 20217:00 amRNSAppointment of Group Chief Executive Officer
18th May 20213:53 pmRNSDirector Declaration
12th May 20212:56 pmRNSDirector Declaration
6th May 20214:17 pmRNSDirector Declaration
6th May 20213:15 pmRNSDirector/PDMR Shareholding
29th Apr 20214:01 pmRNSResult of AGM
21st Apr 20217:00 amRNSQ1 Trading Update
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:56 amRNSAnnual Financial Report
19th Mar 20212:38 pmRNSDirector/PDMR Shareholding
12th Mar 20213:17 pmRNSDirector/PDMR Shareholding
12th Mar 20213:16 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
11th Mar 20219:43 amRNSHolding(s) in Company
4th Mar 202112:43 pmRNSPreliminary results – correction
4th Mar 20217:00 amRNSPreliminary Results year ended 31 December 2020
1st Mar 202112:58 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSStatement RE: Press Speculation
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:38 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSPre-Close Trading Update and Board Update
12th Jan 20219:36 amRNSHolding(s) in Company
6th Jan 20219:10 amRNSDirector Declaration
4th Jan 202110:09 amRNSDirector Declaration
23rd Dec 20204:54 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSAppointment of New Chair
18th Nov 20207:00 amRNSInvestor Seminar
17th Nov 20201:34 pmRNSDirector/PDMR Shareholding
16th Oct 202010:33 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSQ3 Trading Update
7th Oct 20209:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.